888 results on '"Malyszko, Jolanta"'
Search Results
302. Does Lack of ST-Segment Resolution Still Have Prognostic Value 6 Years After an Acute Myocardial Infarction Treated With Coronary Intervention?
303. Comparative Analysis of the New Chronic Kidney Disease Epidemiology Collaboration and the Modification of Diet in Renal Disease Equations for Estimation of Glomerular Filtration Rate in HIV Type 1-Infected Subjects
304. Impact of Diabetes Mellitus on Survival in Patients with End-Stage Renal Disease: A Three-Year Follow-Up
305. Markers of kidney function in the elderly in relation to the new CKD-EPI formula for estimation of glomerular filtration rate
306. Perfusion defects on real-time myocardial contrast echocardiography predict higher mortality in patients with end-stage renal disease – A 3-year follow-up
307. Mechanism of endothelial dysfunction in chronic kidney disease
308. Current Status of the Measurement of Blood Hepcidin Levels in Chronic Kidney Disease
309. Possible Relationship between Neutrophil Gelatinase-Associated Lipocalin, Hepcidin, and Inflammation in Haemodialysed Patients
310. The cardio-renal-anaemia syndrome predicts survival in peritoneally dialyzed patients
311. Biomarkers of Acute Kidney Injury in Different Clinical Settings: A Time to Change the Paradigm?
312. Neutrophil Gelatinase-Associated Lipocalin and Hepcidin: What Do They Have in Common and Is There a Potential Interaction?
313. Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients
314. Urinary and Serum Biomarkers after Cardiac Catheterization in Diabetic Patients with Stable Angina and without Severe Chronic Kidney Disease
315. Type of Renal Replacement Therapy and Residual Renal Function May Affect Prohepcidin and Hepcidin
316. Hepcidin Assays
317. Neutrophil Gelatinase-Associated Lipocalin in Dialyzed Patients Is Related to Residual Renal Function, Type of Renal Replacement Therapy and Inflammation
318. Serum Neutrophil Gelatinase-Associated Lipocalin as a Marker of Renal Function in Patients with Chronic Heart Failure and Coronary Artery Disease
319. Hyporesponsiveness to Erythropoietin Therapy in Hemodialyzed Patients: Potential Role of Prohepcidin, Hepcidin, and Inflammation
320. Serum Prohepcidin and Hepcidin in Hemodialyzed Patients Undergoing Iron Therapy
321. Hemojuvelin: The Hepcidin Story Continues
322. Hepcidin is Linked to Anemia and Inflammation in Peritoneal Dialysis Patients
323. 155: Type of Fistula, NYHA Class and Apelin, Newly Discovered Adipocytokine in Hemodialyzed Patients
324. Serum Neutrophil Gelatinase-Associated Lipocalin as a Marker of Renal Function in Non-Diabetic Patients with Stage 2–4 Chronic Kidney Disease
325. Application of Myocardial Contrast Echocardiography for the Perfusion Assessment in Patients with End-Stage Renal Failure – Comparison with Coronary Angiography
326. Femoral Localization and Higher Ultrafiltration Rate but Not Concentration of Heparin Used for Canal Locking of Hemodialysis Catheter Are Negative Predictors for Its Malfunction
327. 134
328. Thyroid Function, Endothelium, and Inflammation in Hemodialyzed Patients: Possible Relations?
329. Hepcidin in Anemia and Inflammation in Chronic Kidney Disease
330. Chronic kidney disease in patients with significant left main coronary artery disease qualified for coronary artery bypass graft operation.
331. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?
332. Cardiovascular risk in chronic renal disease and transplantation prevention and management
333. Risk Factors of Nontunneled Noncuffed Hemodialysis Catheter Malfunction
334. Increased soluble CD40L levels are reduced by long-term simvastatin treatment in peritoneally dialyzed patients
335. Influence of Simvastatin on Aspects of Thrombogenesis in CAPD Patients
336. Fluvastin therapy affects TAFI concentration in kidney transplant recipients
337. Potassium management with finerenone: Practical aspects
338. A Comprehensive Study on Hemostasis in CAPD Patients Treated with Erythropoietin
339. Comparison of Hemostatic Disturbances between Patients on Capd and Patients on Hemodialysis
340. Renal anaemia treatment in haemodialysis patients in the Central and Eastern European countries in everyday clinical practice follow-up.
341. Leptinaemia in patients dialysed with different buffers and dialysis membranes
342. Vascular and Cardiac Effects of DV-7028, a Selective, 5-HT2-Receptor Antagonist in Rats
343. P16.12: Mortality in Patients on Dialyses and Kidney Transplant Recipients During Pandemic
344. THE COAGULO-LYTIC SYSTEM AND ENDOTHELIAL FUNCTION IN CYCLOSPORINE-TREATED KIDNEY ALLOGRAFT RECIPIENTS
345. Renal Blood Flow and Serotonin Metabolism in Tacrolimus Treated Rats
346. Effects of short-term treatment with mevalotin on platelet aggregation, fibrinolysis, peripheral serotonergic system and serum lipids in Japanese monkeys
347. Changes in serotonergic measures in whole blood and various brain regions of rats administered with the 5-HT1A agonist tandospirone and/or exposed to electric foot-shock
348. Plasma Serotonin and Platelet Aggregation during Ischemia-Reperfusion in Dogs: Effect of Dipyridamole and Coenzyme Q10
349. Renal blood flow, fibrinolysis, and platelet aggregation following tacrolimus (FK 506) treatment in rats
350. Amino acids, serotonin, and 5-hydroxyindoleacetic acid following foot shock in rats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.